Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Cerebral deposition of the beta-amyloid peptide (A beta) is an invariant feature of Alzheimer's disease. Since the original isolation and characterization of A beta (ref. 1) and the subsequent cloning of its precursor protein, no direct evidence for the actual production of discrete A beta has been reported. Here we investigate whether A beta is present in human biological fluids using antibodies specific for an epitope within A beta that spans the site of normal constitutive cleavage. These antibodies were used to construct a sandwich-type enzyme-linked immunosorbent assay that detects A beta in cerebrospinal fluid, plasma and conditioned medium of human mixed-brain cells grown in vitro (see also ref. 14). By affinity chromatography, we have purified and sequenced A beta and a novel A beta fragment from human cerebrospinal fluid and conditioned medium of human mixed-brain cell cultures. These findings demonstrate that A beta is produced and released both in vivo and in vitro. These observations offer new opportunities for developing diagnostic tests for Alzheimer's disease and therapeutic strategies aimed at reducing the cerebral deposition of A beta.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“studies that shed light on the physiological role of Aβ in non-diseased brains show that Aβ plays a role in synaptic transmission and is involved in learning and memory formation [18–22].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [18]
In the citing paper
“Recently, we and others have shown that normal processing of the large amyloid f3 protein precursor ({3-APP) secretes 4-kDa A(3 that is readily detected in human cerebrospinal fluid and in medium conditioned by cultured cells (3)(4)(5)(6).”
From Amyloid β Protein (Aβ) in Alzheimeri's Disease Brain (1995) · cites this paper as [3]
In the citing paper
“The demonstration that A-related peptides with the same N terminals as the CTFs documented here are present in conditioned medium of cultured cells (Seubert et al., 1992;Naslund et al., 1994;Simons et al., 1996;Wang et al., 1996;Xu et al., 1998)”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Seubert et al., 1992
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Self-citationCleavage of Amyloid β Peptide During Constitutive Processing of Its Precursor
Esch, F. S., Keim, P. S., Beattie, E. C., Blacher, R. W., Culwell, A. R., Oltersdorf, T., McClure, D., & Ward, P. J. (1990) · Science · doi:10.1126/science.2111583 · Cited by 1,410
Self-citationMutation of the Alzheimer's Disease Amyloid Gene in Hereditary Cerebral Hemorrhage, Dutch Type
Levy, E., Carman, M. D., Fernandez-Madrid, I. J., Power, M. D., Lieberburg, I., van Duinen, S. G., Bots, G. T. A. M., Luyendijk, W., & Frangione, B. (1990) · Science · doi:10.1126/science.2111584 · Cited by 1,381
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease
Murrell, J., Farlow, M., Ghetti, B., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,127
Tanzi, R. E., McClatchey, A. I., Lamperti, E. D., Villa-Komaroff, L., Gusella, J. F., & Neve, R. L. (1988) · Nature · doi:10.1038/331528a0 · Cited by 1,096
Cited by
Items 501–600 of 1,726
Oyama, R., Yamamoto, H., & Titani, K. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00057-1 · Cited by 104
Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman
Selkoe, D. J. (2003) · Neurochemical Research · doi:10.1023/a:1026065122854 · Cited by 110
Self-citationAmyloid β-protein precursor: new clues to the genesis of Alzheimer's disease
Selkoe, D. J. (1994) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(94)90014-0 · Cited by 114
Self-citationTischer, E., & Cordell, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.21914 · Cited by 96
Tran, M. H., Yamada, K., Olariu, A., Mizuno, M., Ren, X. H., & Nabeshima, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0719fje · Cited by 98
Aluise, C. D., Robinson, R. A. S., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-101083 · Cited by 94
Understanding the roles of mutations in the amyloid precursor protein in Alzheimer disease
Hunter, S., & Brayne, C. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.218 · Cited by 94
Disease-Modifying Therapies in Alzheimer???s Disease: How Far Have We Come?
ll, M. H., Berger, T., & Heneka, M. T. (2006) · Drugs · doi:10.2165/00003495-200666160-00004 · Cited by 106
Polarized secretion of beta-amyloid precursor proteinand amyloid beta-peptide in MDCK cells.
Haass, C., Koo, E. H., Teplow, D. B., & Selkoe, D. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1564 · Cited by 94
Self-citationSoluble multimeric Alzheimer β(1–40) pre-amyloid complexes in dilute solution
LeVine, H. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00052-g · Cited by 113
Chuang, J.-Y., Lee, C.-W., Shih, Y.-H., Yang, T., Yu, L., & Kuo, Y.-M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033120 · Cited by 95
“Soluble forms of Ab exist in normal human brains and CSF [9,10] and except for a few familial AD cases, the expression of APP and production of Ab are not increased in most sporadic”
BackgroundRockenstein, E., Mante, M., Alford, M., Adame, A., Crews, L., Hashimoto, M., Esposito, L., Mucke, L., & Masliah, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507016200 · Cited by 95
Giri, R., Selvaraj, S., Miller, C. A., Hofman, F., Yan, S. D., Stern, D., Zlokovic, B. V., & Kalra, V. K. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00293.2001 · Cited by 93
“Soluble A 1O40 is the major form of circulating A , whereas amyloiodogenic A 1O42, the major constituent of senile plaques, is present in minor amounts in the circulation (2, 13, 20, 22).”
Haass, C., Capell, A., Citron, M., Teplow, D. B., & Selkoe, D. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6186 · Cited by 80
Self-citationJacobsen, J. S., Reinhart, P. H., & Pangalos, M. N. (2005) · NeuroRx · doi:10.1602/neurorx.2.4.612 · Cited by 102
“The final mechanism proposed is based on the “peripheral amyloid sink” hypothesis(70,71,90) and was developed using a monoclonal antibody named m266.(91) This antibody is directed to epitopes within the central domain of A and binds only to soluble forms of this peptide.”
BackgroundSkaat, H., & Margel, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.110 · Cited by 107
“Ab is continuously secreted by normal cells in culture and is detected as a soluble peptide in the plasma and cerebrospinal fluid of healthy individuals [10,11].”
BackgroundA Mobile Precursor Determines Amyloid-β Peptide Fibril Formation at Interfaces
Shen, L., Adachi, T., Bout, D. V., & Zhu, X. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305398f · Cited by 101
Plasma Levels of amyloid β proteins Aβ1–40 and Aβ1–42(43) are elevated in Down's syndrome
Tokuda, T., Fukushima, T., Ikeda, S., Sekijima, Y., Shoji, S., Yanagisawa, N., & Tamaoka, A. (1997) · Annals of Neurology · doi:10.1002/ana.410410220 · Cited by 92
AßT Amyloidogenesis: Unique, or Variation on a Systemic Theme
Kisilevsky, R., Fraser, P. E., & Benson, M. D. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709082674 · Cited by 103
Effects of SEL-12 presenilin on LIN-12 localization and function in Caenorhabditis elegans
Levitan, D., & Greenwald, I. (1998) · Development · doi:10.1242/dev.125.18.3599 · Cited by 92
The length of Amyloid-β in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type
Castaño, E. M., Prelli, F., Soto, C., Beavis, R., Matsubara, E., Shoji, M., & Frangione, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32185 · Cited by 91
Low‐n oligomers as therapeutic targets of Alzheimer’s disease
Ono, K., & Yamada, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07187.x · Cited by 76
Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
Imbimbo, B. P., Ottonello, S., Frisardi, V., Solfrizzi, V., Greco, A., Seripa, D., Pilotto, A., & Panza, F. (2012) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.93 · Cited by 90
Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic
Kepp, K. P., & Squitti, R. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2019.06.018 · Cited by 96
Plasma p‐tau231, p‐tau181, PET Biomarkers, and Cognitive Change in Older Adults
Meyer, P., Ashton, N. J., Karikari, T. K., Strikwerda‐Brown, C., Köbe, T., Gonneaud, J., Pichet Binette, A., Ozlen, H., Yakoub, Y., Simrén, J., et al. (2022) · Annals of Neurology · doi:10.1002/ana.26308 · Cited by 91
Alzheimer’s disease – the journey of a healthy brain into organ failure
Golde, T. E. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00523-1 · Cited by 88
Kerchner, G. A., & Boxer, A. L. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.493872 · Cited by 87
“This monoclonal antibody, a humanized version of the mouse antibody m266, raised against Ab13--28 [36,37], differs from bapineuzumab in at least three ways: First, by recognizing a distinct epitope in the central portion of the peptide, it is able to recognize variousN-terminal truncation species (such as Ab3--42) tha…”
GM1 Ganglioside-Bound Amyloid β-Protein in Alzheimer’s Disease Brain
Yanagisawa, K., & Ihara, Y. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00032-3 · Cited by 92
Alzheimer's soluble amyloid β is a normal component of human urine
Ghiso, J., Calero, M., Matsubara, E., Governale, S., Chuba, J., Beavis, R., Wisniewski, T., & Frangione, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00400-6 · Cited by 89
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
Davidsson, P., & Sjögren, M. J. C. (2005) · Disease Markers · doi:10.1155/2005/848676 · Cited by 93
Correlation Between Aβx-40–, Aβx-42–, and Aβx-43–Containing Amyloid Plaques and Cognitive Decline
Parvathy, S., Davies, P., Haroutunian, V., Purohit, D. P., Davis, K. L., Mohs, R. C., Park, H., Moran, T. M., Chan, J. Y., & Buxbaum, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.2025 · Cited by 89
Short Aβ peptides attenuate Aβ42 toxicity in vivo
Moore, B. D., Martin, J., de Mena, L., Sanchez, J., Cruz, P. E., Ceballos-Diaz, C., Ladd, T. B., Ran, Y., Levites, Y., Kukar, T. L., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20170600 · Cited by 89
“In some instances, additional Aβ peptides (e.g., Aβ1–34, 1–36, 1–41, and 1–43) are generated at detectable levels (Seubert et al., 1992; Wang et al., 1996; Golde et al., 2013).”
Galloway, S., Jian, L., Johnsen, R. D., Chew, S., & Mamo, J. C. L. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.07.003 · Cited by 97
“However, cerebrospinal fluid is an ultrafiltrate of plasma, raising the possibility that exogenous delivery of Ah could exacerbate cerebral load [4,5].”
BackgroundInhibitory Effect of Copper(II) on Zinc(II)-Induced Aggregation of Amyloid β-Peptide
Suzuki, K., Miura, T., & Takeuchi, H. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5263 · Cited by 96
Inhibition of Amyloid β-Protein Production in Neural Cells by the Serine Protease Inhibitor AEBSF
Citron, M., Diehl, T. S., Capell, A., Haass, C., Teplow, D. B., & Selkoe, D. J. (1996) · Neuron · doi:10.1016/s0896-6273(00)80290-1 · Cited by 89
Self-citationThe missing link in the amyloid cascade of Alzheimer’s disease – Metal ions
Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 104
Moir, R. D., Tseitlin, K. A., Soscia, S., Hyman, B. T., Irizarry, M. C., & Tanzi, R. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414176200 · Cited by 90
The progression of β-amyloid deposition in the frontal cortex of the aged canine
Satou, T., Cummings, B. J., Head, E., Nielson, K. A., Hahn, F. F., Milgram, N. W., Velázquez, P., Cribbs, D. H., Tenner, A. J., & Cotman, C. W. (1997) · Brain Research · doi:10.1016/s0006-8993(97)81684-8 · Cited by 106
Metalloendopeptidase EC 3.4.24.15 Is Necessary for Alzheimer's Amyloid-β Peptide Degradation
Yamin, R., Malgeri, E. G., Sloane, J. A., McGraw, W. T., & Abraham, C. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18777 · Cited by 88
Spike bursts increase amyloid-β 40/42 ratio by inducing a presenilin-1 conformational change
Dolev, I., Fogel, H., Milshtein-Parush, H., Berdichevsky, Y., Lipstein, N., Brose, N., Gazit, N., & Slutsky, I. (2013) · Nature Neuroscience · doi:10.1038/nn.3376 · Cited by 97
Ramsden, M., Henderson, Z., & Pearson, H. A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03547-3 · Cited by 99
Ganglioside GM1-Mediated Amyloid-beta Fibrillogenesis and Membrane Disruption
Chi, E. Y., Frey, S. L., & Lee, K. Y. C. (2007) · Biochemistry · doi:10.1021/bi062177x · Cited by 89
Oligomerization and fibril assembly of the amyloid-β protein
Roher, A. E., Baudry, J. Y., Chaney, M. O., Kuo, Y., Stine, W. B., & Emmerling, M. R. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00030-2 · Cited by 106
Intracellular copper deficiency increases amyloid-β secretion by diverse mechanisms
Cater, M. A., McInnes, K. T., Li, Q.-X., Volitakis, I., La Fontaine, S., Mercer, J. F. B., & Bush, A. I. (2008) · Biochemical Journal · doi:10.1042/bj20080103 · Cited by 86
Gizaw, S. T., Ohashi, T., Tanaka, M., Hinou, H., & Nishimura, S. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.03.009 · Cited by 89
“5 amyloid in AD brains is most likely to have been produced locally and also appears to occur in all cells and tissues that can be detected in plasma and cerebrospinal fluid (CSF) [2,6].”
BackgroundFree radical theory of aging: Alzheimer’s disease pathogenesis
Harman, D. (1995) · AGE · doi:10.1007/bf02436085 · Cited by 89
Genetic factors in Alzheimer's disease: A review of recent advances
Levy‐Lahad, E., & Bird, T. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400604 · Cited by 96
Fanlo-Ucar, H., Picón-Pagès, P., Herrera-Fernández, V., ILL‐Raga, G., & Muñoz, F. J. (2024) · Antioxidants · doi:10.3390/antiox13101208 · Cited by 101
Lysosomal processing of amyloid precursor protein to A β peptides: a distinct role for cathepsin S
Munger, J. S., Haass, C., Lemere, C. A., Shi, G. P., Wong, W. S. F., Teplow, D. B., Selkoe, D. J., & Chapman, H. A. (1995) · Biochemical Journal · doi:10.1042/bj3110299 · Cited by 85
Self-citationSurface chemistry of Alzheimer's disease: A Langmuir monolayer approach
Thakur, G., Mićić, M., & Leblanc, R. M. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.07.043 · Cited by 89
Sopher, B. L., Fukuchi, K.-I., Smith, A. C., Leppig, K. A., Furlong, C. E., & Martin, G. M. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90092-2 · Cited by 84
Wísniewski, H. M., Frackowiak, J., & Mazur‐Kolecka, B. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11129-7 · Cited by 92
Xu, H., Sweeney, D., Greengard, P., & Gandy, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4081 · Cited by 85
Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83
Bertram, S., Brixius, K., & Brinkmann, C. K. (2016) · Endocrine · doi:10.1007/s12020-016-0976-8 · Cited by 94
“APP is also expressed in several tissues other than the brain and soluble Ab is detectable in blood [84].”
Inhibitors of Aβ production: solid-phase synthesis and SAR of α-hydroxycarbonyl derivatives
Wallace, O. B., Smith, D. W., Deshpande, M., Polson, C. T., & Felsenstein, K. M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)01058-2 · Cited by 83
Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology
Moon, M., Song, H., Hong, H. J., Nam, D. W., Cha, M.-Y., Oh, M. S., Yu, J., Ryu, H., & Mook‐Jung, I. (2012) · Cell Death and Differentiation · doi:10.1038/cdd.2012.161 · Cited by 97
Jiang, D., Li, X., Liu, L., Yagnik, G. B., & Zhou, F. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp9095375 · Cited by 81
Preclinical Alzheimer disease: Brain oxidative stress, Aβ peptide and proteomics
Aluise, C. D., Robinson, R. A. S., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M., Markesbery, W. R., & Butterfield, D. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.011 · Cited by 83
“Senile plaques are mainly composed of amyloid beta peptide (Aβ), the latter produced via sequential cleavages of amyloid precursor protein (APP) by beta- and gamma-secretases (Haass et al., 1992; Shoji et al., 1992; Seubert et al., 1992).”
BackgroundReceptor-Mediated Transport of Human Amyloid β-Protein 1–40 and 1–42 at the Blood–Brain Barrier
Poduslo, J. F., Curran, G. L., Sanyal, B., & Selkoe, D. J. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0238 · Cited by 83
“…as in peripheral tissues (Haass et al., 1992) and is found in the CSF and plasma of both normal individuals and AD patients (Shoji et al., 1992; Seubert et al., 1992; Scheuner et al., 1996), the source of Ab that contributes to this deposition needs to be identified to facilitate our…”
BackgroundSelf-citationβ-Amyloid (Aβ) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease
Andreasen, N., & Blennow, K. (2002) · Peptides · doi:10.1016/s0196-9781(02)00056-6 · Cited by 97
Clements, A., Walsh, D. M., Williams, C. H., & Allsop, D. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90129-9 · Cited by 83
The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide
Ashur‐Fabian, O., Segal-Ruder, Y., Skutelsky, E., Brenneman, D. E., Steingart, R. A., Giladi, E., & Gozes, I. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.005 · Cited by 89
Itakura, M., Nakajima, H., Kubo, T., Semi, Y., Kume, S., Higashida, S., Kaneshige, A., Kuwamura, M., Harada, N., Kita, A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.669291 · Cited by 83
“The concentration of A in vivo is reported to be 5 nM (51, 52), whereas aggregation in vitro requires a concentration nearly 3 orders of magnitude greater than in vivo values (53).”
BackgroundConcentrations of amyloid β protein in cerebrospinal fluid of patients with alzheimer's disease
Van Gool, W. A., Walstra, G. J. M., Bolhuis, P. A., Kuiper, M. A., & Wolters, E. C. (1995) · Annals of Neurology · doi:10.1002/ana.410370221 · Cited by 82
Ectodomain Phosphorylation of β-Amyloid Precursor Protein at Two Distinct Cellular Locations
Walter, J., Capell, A., Hung, A. Y., Langen, H., Schnölzer, M., Thinakaran, G., Sisodia, S. S., Selkoe, D. J., & Haass, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1896 · Cited by 67
Self-citationInhibition of Alzheimer β-Peptide Fibril Formation by Serum Amyloid P Component
Janciauskiene, S., de Frutos, P. G., Carlemalm, E., Dahlbäck, B., & Eriksson, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26041 · Cited by 82
Human antibodies reactive with beta-amyloid protein in Alzheimer's disease.
Gaskin, F., Finley, J., Fang, Q., Xu, S., & Fu, S. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.4.1181 · Cited by 84
“Recently 3-AP was reported to be found in various tissues and in circulation ( 13 , 14).”
BackgroundSolution Structure Model of Residues 1−28 of the Amyloid β-Peptide When Bound to Micelles
Marcinowski, K. J., Shao, H., Clancy, E. L., & Zagorski, M. G. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9738687 · Cited by 90
Platelets and Alzheimer’s disease: Potential of APP as a biomarker
Evin, G. (2012) · World Journal of Psychiatry · doi:10.5498/wjp.v2.i6.102 · Cited by 80
Enhanced aggregation and β structure of amyloid β peptide after coincubation with C1Q
Webster, S., O'Barr, S., & Rogers, J. (1994) · Journal of Neuroscience Research · doi:10.1002/jnr.490390412 · Cited by 81
Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160550 · Cited by 81
Androgens regulate neprilysin expression: role in reducing β‐amyloid levels
Yao, M., Nguyen, T. V., Rosario, E. R., Ramsden, M., & Pike, C. J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05341.x · Cited by 80
Hock, C., Golombowski, S., Müller-Spahn, F., Naser, W., Beyreuther, K., Mönning, U., Schenk, D., Vigo-Pelfrey, C., Bush, A. M., Moir, R., et al. (1998) · European Neurology · doi:10.1159/000007917 · Cited by 81
Self-citationPrice, J. M., Chi, X., Hellermann, G., & Sutton, E. T. (2001) · Neurological Research · doi:10.1179/016164101101198758 · Cited by 80
Hashimoto, M., Shahdat, H. M., Yamashita, S., Katakura, M., Tanabe, Y., Fujiwara, H., Gamoh, S., Miyazawa, T., Arai, H., Shimada, T., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05731.x · Cited by 78
“%) found circulating in cerebrospinal fluid, while Ab1-42 and other lengths are minor components (Haass et al.1992; Seubert et al. 1992; Skovronsky et al. 1998).”
Backgroundβ‐Amyloid aggregation and heterogeneous nucleation
Srivastava, A. K., Pittman, J. M., Zerweck, J., Venkata, B. S., Moore, P. C., Sachleben, J. R., & Meredith, S. C. (2019) · Protein Science · doi:10.1002/pro.3674 · Cited by 81
Ray, I., Chauhan, A., Węgiel, J., & Chauhan, V. P. S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02315-x · Cited by 86
Mak, K., Yang, F., Vinters, H. V., Frautschy, S. A., & Cole, G. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)91725-6 · Cited by 81
Ertekin-Taner, N. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg343 · Cited by 81
Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus.
Saido, T. C., Yokota, M., Maruyama, K., Yamao-Harigaya, W., Tani, E., Ihara, Y., & Kawashima, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36599-7 · Cited by 81
Fuller, S. J., Storey, E., Li, Q.-X., Smith, A. I., Beyreuther, K., & Masters, C. L. (1995) · Biochemistry · doi:10.1021/bi00025a015 · Cited by 80
Korecka, M., & Shaw, L. M. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15465 · Cited by 88
Pirttilä, T., Kim, K. S., Mehta, P. D., Frey, H., & Wísniewski, H. M. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90140-6 · Cited by 88
Do anti-amyloid beta protein antibody cross reactivities confound Alzheimer disease research?
Hunter, S., & Brayne, C. (2017) · Journal of Negative Results in BioMedicine · doi:10.1186/s12952-017-0066-3 · Cited by 77
Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration
Bernales, S., Soto, M. M., & McCullagh, E. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00005 · Cited by 78
Polgár, T., & Keserű, G. M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049133b · Cited by 78
Chung, R. S., Howells, C., Eaton, E. D., Shabala, L., Zovo, K., Palumaa, P., Sillard, R., Woodhouse, A., Bennett, W. R., Ray, S., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012030 · Cited by 89
Lee, E. B., Skovronsky, D. M., Abtahian, F., Doms, R. W., & Lee, V. M.-Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210105200 · Cited by 79
Soto, C. A. (1999) · Journal of Molecular Medicine · doi:10.1007/s001090050371 · Cited by 87
Sandbrink, R., Masters, C. L., & Beyreuther, K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36778-9 · Cited by 78
Slack, B. E., Breu, J., Petryniak, M. A., Srivastava, K., & Wurtman, R. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8337 · Cited by 81
The amyloid precursor protein of Alzheimer disease in human brain and blood
Li, Q.-X., Fuller, S. J., Beyreuther, K., & Masters, C. L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.4.567 · Cited by 77
Human BACE Forms Dimers and Colocalizes with APP
Schmechel, A., Strauss, M., Schlicksupp, A., Pipkorn, R., Haass, C., Bayer, T. A., & Multhaup, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402785200 · Cited by 79
Amyloid beta acts synergistically as a pro-inflammatory cytokine
LaRocca, T. J., Cavalier, A. N., Roberts, C. M., Lemieux, M. R., Ramesh, P., Garcia, M. A., & Link, C. D. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105493 · Cited by 78
Pappolla, M. A., Smith, M. A., Bryant‐Thomas, T., Bazan, N., Petanceska, S. S., Perry, G. L., Thal, L. J., Sano, M., & Refolo, L. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00841-9 · Cited by 85
Ramsden, M., Plant, L. D., Webster, N. J., Vaughan, P. F. T., Henderson, Z., & Pearson, H. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00618.x · Cited by 77
“This is surprising, as soluble Ab has been detected at nanomolar concentrations in the cerebrospinal ¯uid of healthy human subjects (Seubert et al. 1992) and is secreted into growth media by cultured neurones (Haass et al. 1992).”
BackgroundEffect of alkalizing agents on the processing of the β-amyloid precursor protein
Schrader‐Fischer, G., & Paganetti, P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00002-9 · Cited by 92
Poon, H. F., Farr, S. A., Banks, W. A., Pierce, W. M., Klein, J. B., Morley, J. E., & Butterfield, D. A. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.020 · Cited by 76
“under entirely normal cellular conditions [10,43,72,73] during the internalization and endosomal processing of APP [50,65].”
Glycation and Microglial Reaction in Lesions of Alzheimer's Disease
Dickson, D. W., Sinicropi, S., Yen, S.-H. C., Ko, L., Mattiace, L. A., Bucala, R., & Vlassara, H. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00116-9 · Cited by 87
Metadata
- Authors
- Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., McCormack, R., Wolfert, R., Selkoe, D., Lieberburg, I., & Schenk, D.
- Affiliations
- Austrian Academy of Sciences (AT)
- Venue
- Nature
- Published
- 1992-09
- Volume
- 359
- Issue
- 6393
- Pages
- 325-327
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2086278983
- Cited by
- 1,731
- References
- 28
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 32 · 2023: 19 · 2022: 22 · 2021: 31 · 2020: 28 · 2019: 25 · 2018: 35 · 2017: 39 · 2016: 31 · 2015: 48 · 2014: 46 · 2013: 39 · 2012: 50
- FWCI
- 72.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, cerebrospinal fluid, plasma, conditioned medium, sandwich ELISA, affinity chromatography, epitope-specific antibodies, amyloid deposition, diagnostic biomarkers
- MeSH terms
- Alzheimer Disease, Amino Acid Sequence, Antibodies, Monoclonal, Brain, Cells, Cultured, Cross Reactions, Enzyme-Linked Immunosorbent Assay, Humans, Molecular Sequence Data, Peptide Fragments, Radioimmunoassay, Solubility, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.